{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:13Z","timestamp":1761513493702,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.clbc.2015.03.007","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T16:51:04Z","timestamp":1430585464000},"page":"e257-e262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor\u2013Positive Early Breast Cancer: A Biologic Study"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7307-2679","authenticated-orcid":false,"given":"Alessandra","family":"Balduzzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Bagnardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Dellapasqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Cardillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cancello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Iorfida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Ghisini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Viale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Intra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Luini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aron","family":"Goldhirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2015.03.007_bib1","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/jnci\/93.22.1714","article-title":"Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol","volume":"93","author":"Song","year":"2001","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2015.03.007_bib2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6601611","article-title":"Targeting estrogen to kill the cancer but not the patient","volume":"90","author":"Lewis","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2015.03.007_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jsbmb.2004.12.032","article-title":"Estrogen-induced apoptosis in breast cancer model resistant to long-term estrogen withdrawal","volume":"94","author":"Lewis","year":"2005","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clbc.2015.03.007_bib4","first-page":"2028","article-title":"Antitumor action of physiological estradiol on tamoxifen stimulated breast tumors grown in athymic mice","volume":"6","author":"Yao","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2015.03.007_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1010619225209","article-title":"High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy","volume":"67","author":"L\u00f6nning","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2015.03.007_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.clbc.2015.03.007_bib7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0959-8049(99)00005-2","article-title":"Prediction of response to primary chemotherapy for operable breast cancer","volume":"35","author":"Colleoni","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2015.03.007_bib8","first-page":"324","article-title":"Phase I study of the oral non-steroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women","volume":"77","author":"Iveson","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clbc.2015.03.007_bib9","first-page":"2338","article-title":"Impact of Tamoxifen on the\u00a0pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in\u00a0postmenopausal women with breast cancer","volume":"5","author":"Dowsett","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2015.03.007_bib10","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1158\/0008-5472.CAN-07-5999","article-title":"Stopping treatment can reverse acquired resistance to letrozole","volume":"68","author":"Sabnis","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2015.03.007_bib11","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/jnci\/djg079","article-title":"Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer","volume":"95","author":"Osipo","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2015.03.007_bib12","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2015.03.007_bib13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jama.2009.1204","article-title":"Lower-dose vs high-dose oral estradiol therapy of hormone receptor\u2013positive, aromatase inhibitor\u2013resistant advanced breast cancer","volume":"302","author":"Ellis","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2015.03.007_bib14","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.2007.13.5822","article-title":"Double blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior non-steroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT","volume":"26","author":"Chia","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2015.03.007_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsbmb.2005.04.026","article-title":"Model systems: mechanisms involved in the loss of sensitivity to letrozole","volume":"95","author":"Brodie","year":"2005","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clbc.2015.03.007_bib16","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1200\/JCO.2008.17.5190","article-title":"The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer\u2014survival or death?","volume":"26","author":"Jordan","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2015.03.007_bib17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/oxfordjournals.annonc.a058286","article-title":"Response after withdrawal of tamoxifen and progestogens in advanced breast cancer","volume":"3","author":"Howell","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2015.03.007_bib18","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","article-title":"A\u00a0comparison of letrozole and tamoxifen in\u00a0postmenopausal women with early breast cancer","volume":"353","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2015.03.007_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S8756-3282(97)00078-1","article-title":"Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients","volume":"21","author":"Christiansen","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.clbc.2015.03.007_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF01623829","article-title":"Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption","volume":"3","author":"Eastell","year":"1993","journal-title":"Osteoporos Int"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820915000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820915000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:14:07Z","timestamp":1761513247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820915000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1526820915000713"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2015.03.007","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor\u2013Positive Early Breast Cancer: A Biologic Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2015.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}